Newsroom

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Indxx Global Aerospace & Defence UCITS ETF 23.01.2026 MISL.LN IE000NVDQXE1 3,125,002.00 USD 114,663,085.03 36.692  ...

DUBLIN--(BUSINESS WIRE)--The "Next Generation Drug Conjugates Market: Industry Trends and Global Forecasts, Till 2035" has been added to ResearchAndMarkets.com's offering. The global next-generation drug conjugates market is projected to surge from USD 4.2 billion in the current year to USD 15.5 billion by 2035, displaying a CAGR of 14.0% during the forecast period. Next-generation drug conjugates are emerging as significant targeted treatments, particularly for rare diseases and various cancer...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest Nasdaq-100 Moderate Buffer UCITS ETF - September 23.01.2026 QSEP.LN IE000FQ808R5 450,002.00 USD 10,373,286.78 23.052  ...

CHICAGO--(BUSINESS WIRE)--Advyzon Investment Management (AIM), a seamlessly integrated unified investment solutions platform through the comprehensive wealthtech platform Advyzon, announced an exciting new relationship with Schwab Asset Management®, offering Wasmer Schroeder® Strategies, a provider of a broad host of portfolio strategies across the duration, credit, and tax-efficiency spectrum. Schwab Asset Management and its Wasmer Schroeder Strategies will be the first fixed income focused st...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Rising Dividend Achievers UCITS ETF 23.01.2026 RDVY LN IE000K5F6EL4 600,002.00 USD 13,640,693.05 22.734  ...

DUBLIN--(BUSINESS WIRE)--The "AI in Drug Discovery Market, till 2040: Distribution by Drug Discovery Steps, Therapeutic Area, and Key Geographical Regions: Industry Trends and Global Forecasts" has been added to ResearchAndMarkets.com's offering. The global AI in drug discovery market is projected to expand dramatically, from USD 1.81 billion this year to USD 41.08 billion by 2040, growing at a CAGR of 25%. This growth is driven by innovations like virtual screening, predictive modeling, and de...

MUNICH & SANTA CLARA, Calif.--(BUSINESS WIRE)--PlusAI, a leader in AI-based virtual driver software for autonomous trucks, and the TRATON GROUP, one of the world’s leading commercial vehicle manufacturers, today announced to expand their global partnership to accelerate the development and scaled deployment of on-highway autonomous trucking solutions in the U.S. and Europe. The announcement comes as PlusAI moves towards a public listing via its previously announced business combination with Chu...

VANCOUVER, British Columbia--(BUSINESS WIRE)--Solstice Gold Corp. (TSXV: SGC) (“Solstice” or the “Company”) is pleased to announce it has entered into agreements for the acquisition of two patented claims and one unpatented claim totaling 47.2 hectares (0.47 km²), strategically located immediately east of the Red Cedar Discovery at its 100%-owned Strathy Gold Project (the “Project”) in Ontario. The Project, which now covers approximately 46 km², is situated within the Temagami Greenstone Belt o...

COEUR D'ALENE, Idaho--(BUSINESS WIRE)--Hecla Mining Company (NYSE:HL) ("Hecla" or the "Company") today announced its preliminary metals production for the fourth quarter and full year of 2025 and provided 2026 Guidance. HIGHLIGHTS Silver production of 17.0 million ounces exceeded 2024 production by over 5% and came in at the top end of consolidated silver production guidance. All silver operations met production guidance, with Lucky Friday producing 5.3 million ounces and exceeding the top end...

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR) today announced positive results from its phase 1 study of miroliverELAP®, an external liver assist product, in patients with acute forms of liver failure, acute-on-chronic liver failure, and severe acute alcoholic hepatitis, collectively called acute liver failure (ALF).2 Developed by Miromatrix Medical Inc., a wholly owned subsidiary of United Therapeutics, miroliverELAP consists...